The review also identified ongoing trials evaluating markers more directly related to tumor cell activity: caspase-3 (a marker of apoptosis), hypoxia-inducible factor (HIF)-1α, NF-κB (transcription factors associated with cell proliferation), and VEGF. The gene discussed is VEGFA; the disease is neoplasm.